| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 672304 | Null | 0.0392716453377535 | 0.28173985 |
| NSC 676794 | Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[3-O-(D-.apio.-.beta.-D-ribofuranosy)- 4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-D-xylopy | 0.0392716453377535 | 0.069762878 |
| NSC 684409 | 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone | 0.0392716453377535 | -0.037337563 |
| NSC 693169 | Null | 0.0392716453377535 | 0.11223694 |
| NSC 699934 | Null | 0.0392716453377535 | 0.32094627 |
| NSC 700862 | 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- | 0.0392716453377535 | 0.18440022 |
| NSC 715407 | Null | 0.0392716453377535 | 0.16020651 |
| NSC 718781 | Erlotinib hydrochloride | 0.0392716453377535 | -0.25710528 |
| NSC 720320 | 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole | 0.0392716453377535 | -0.13548075 |
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.0392716453377535 | 0.22407113 |